Johnson & Johnson logo

Johnson & Johnson dividend paidNYSE: JNJ

TTMAnnual

Dividend paid (quarterly)

-

28 September 2024

Performance
Most recent-
1 year-
3 years-
5 years-

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (quarterly) performance

Most recent change
JNJ-
ABBV-0.8%
NVO-100.9%
UNH+0.1%
MRK+1.9%
AZN-99.4%
NVS-53.6%
1 year change
JNJ-
ABBV+4.7%
NVO-101.9%
UNH+11.4%
MRK+7.1%
AZN-98.8%
NVS+100.0%
3 years change
JNJ-
ABBV+18.8%
NVO-103.1%
UNH+41.7%
MRK+20.4%
AZN-98.8%
NVS+100.0%
5 years change
JNJ-
ABBV+72.8%
NVO-103.6%
UNH+89.2%
MRK+42.5%
AZN-98.5%
NVS+100.0%

Dividend paid (quarterly) performance

JNJABBVNVOUNHMRKAZNNVS
Most recent--0.8%-100.9%+0.1%+1.9%-99.4%-53.6%
1 year-+4.7%-101.9%+11.4%+7.1%-98.8%+100.0%
3 years-+18.8%-103.1%+41.7%+20.4%-98.8%+100.0%
5 years-+72.8%-103.6%+89.2%+42.5%-98.5%+100.0%
FAQ

What is Johnson & Johnson dividend paid (quarterly)?

Johnson & Johnson dividend paid (quarterly) is

How has Johnson & Johnson dividend paid (quarterly) changed over the year?

Over the past year, Johnson & Johnson dividend paid (quarterly) has not changed. During the same period, AbbVie has increased by 4.7%, Novo Nordisk A/S has decreased by 101.9%, UnitedHealth Group Incorporated has grown by 11.4%, Merck & Co has increased by 7.1%, AstraZeneca has decreased by 98.8%, Novartis AG has grown by 100.0%

How has Johnson & Johnson dividend paid (quarterly) changed over the 3 years?

During the last 3 years, Johnson & Johnson dividend paid (quarterly) has not changed. Over the same period, AbbVie has increased by 18.8%, Novo Nordisk A/S has decreased by 103.1%, UnitedHealth Group Incorporated has grown by 41.7%, Merck & Co has increased by 20.4%, AstraZeneca has decreased by 98.8%, Novartis AG has grown by 100.0%

How has Johnson & Johnson dividend paid (quarterly) changed over the 5 years?

For the past 5 years, Johnson & Johnson dividend paid (quarterly) has not changed. In the same period, AbbVie has increased by 72.8%, Novo Nordisk A/S has decreased by 103.6%, UnitedHealth Group Incorporated has grown by 89.2%, Merck & Co has increased by 42.5%, AstraZeneca has decreased by 98.5%, Novartis AG has grown by 100.0%